| Primary |
| Osteoporosis |
61.3% |
| Osteopenia |
7.3% |
| Osteoporosis Postmenopausal |
5.7% |
| Hypertension |
5.4% |
| Prophylaxis |
4.1% |
| Osteoporosis Prophylaxis |
2.9% |
| Back Pain |
1.5% |
| Supplementation Therapy |
1.3% |
| Lip And/or Oral Cavity Cancer |
1.2% |
| Hypothyroidism |
1.1% |
| Diabetes Mellitus |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Pain |
0.9% |
| Hyperlipidaemia |
0.8% |
| Depression |
0.8% |
| Constipation |
0.8% |
| Gastritis |
0.8% |
| Breast Cancer |
0.7% |
| Reflux Oesophagitis |
0.7% |
| Bone Disorder |
0.7% |
|
| Breast Cancer |
16.5% |
| Pulmonary Embolism |
10.2% |
| Thrombosis |
8.2% |
| Transient Ischaemic Attack |
6.0% |
| Deep Vein Thrombosis |
5.5% |
| Cerebrovascular Accident |
4.7% |
| Visual Acuity Reduced |
4.4% |
| Endometrial Cancer |
4.2% |
| Myocardial Infarction |
4.2% |
| Osteonecrosis |
4.2% |
| Cerebral Infarction |
4.1% |
| Platelet Count Decreased |
3.7% |
| Uterine Cancer |
3.5% |
| Spinal Fracture |
3.3% |
| Pain In Extremity |
3.1% |
| Vision Blurred |
3.1% |
| Hip Fracture |
3.0% |
| Vaginal Haemorrhage |
2.9% |
| Muscle Spasms |
2.7% |
| Weight Increased |
2.7% |
|
| Secondary |
| Osteoporosis |
45.6% |
| Hormone Replacement Therapy |
10.6% |
| Product Used For Unknown Indication |
8.0% |
| Hypertension |
5.0% |
| Drug Use For Unknown Indication |
3.9% |
| Osteopenia |
3.6% |
| Pain |
2.7% |
| Diabetes Mellitus |
2.6% |
| Rheumatoid Arthritis |
2.3% |
| Cardiac Disorder |
2.2% |
| Hypothyroidism |
2.2% |
| Depression |
2.0% |
| Bone Disorder |
1.3% |
| Osteoarthritis |
1.3% |
| Osteoporosis Prophylaxis |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Nasopharyngitis |
1.2% |
| Osteoporosis Postmenopausal |
1.0% |
| Blood Pressure |
0.9% |
| Dementia Alzheimer's Type |
0.9% |
|
| Breast Cancer |
9.2% |
| Breast Cancer Female |
8.7% |
| Drug Ineffective |
8.2% |
| Weight Decreased |
7.2% |
| Spinal Fracture |
6.8% |
| Pain |
5.8% |
| Weight Increased |
5.8% |
| Visual Acuity Reduced |
4.8% |
| Bone Pain |
4.3% |
| Nausea |
4.3% |
| Road Traffic Accident |
4.3% |
| Vomiting |
4.3% |
| Thrombosis |
3.9% |
| Femur Fracture |
3.4% |
| Muscle Spasms |
3.4% |
| Tricuspid Valve Incompetence |
3.4% |
| Urinary Tract Infection |
3.4% |
| Breast Cancer Metastatic |
2.9% |
| Ovarian Cancer |
2.9% |
| Spinal Laminectomy |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.4% |
| Osteoporosis |
17.6% |
| Drug Use For Unknown Indication |
10.5% |
| Rheumatoid Arthritis |
9.9% |
| Hypertension |
7.1% |
| Depression |
3.7% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Osteopenia |
3.3% |
| Prophylaxis |
2.6% |
| Pain |
2.6% |
| Blood Cholesterol Increased |
2.4% |
| Asthma |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Diabetes Mellitus |
1.9% |
| Atrial Fibrillation |
1.7% |
| Insomnia |
1.6% |
| Hypothyroidism |
1.6% |
| Arthritis |
1.5% |
| Smoking Cessation Therapy |
1.4% |
| Anxiety |
1.3% |
|
| Vomiting |
12.2% |
| Nausea |
9.9% |
| Weight Decreased |
7.9% |
| Weight Increased |
7.1% |
| Urinary Tract Infection |
6.3% |
| Drug Ineffective |
5.2% |
| Rash |
4.9% |
| Somnolence |
4.3% |
| Oedema Peripheral |
4.0% |
| Pain |
3.8% |
| Wheezing |
3.8% |
| Wound Infection Staphylococcal |
3.8% |
| Pyrexia |
3.7% |
| Pneumonia |
3.6% |
| Death |
3.5% |
| Pain In Extremity |
3.5% |
| Tremor |
3.2% |
| Vision Blurred |
3.2% |
| Wrist Fracture |
3.2% |
| White Blood Cell Count Increased |
3.0% |
|
| Interacting |
| Obsessive-compulsive Disorder |
19.7% |
| Drug Use For Unknown Indication |
16.4% |
| Osteoporosis |
13.1% |
| Vulvovaginal Candidiasis |
11.5% |
| Product Used For Unknown Indication |
8.2% |
| Bone Density Decreased |
4.9% |
| Breast Cancer |
4.9% |
| Blood Pressure High |
3.3% |
| Bone Disorder |
3.3% |
| Constipation |
3.3% |
| Fibromyalgia |
3.3% |
| Back Pain |
1.6% |
| Diarrhoea |
1.6% |
| High Cholesterol |
1.6% |
| Neck Pain |
1.6% |
| Pain In Spine |
1.6% |
|
| Staphylococcal Infection |
33.3% |
| Drug Interaction |
22.2% |
| Abnormal Weight Gain |
11.1% |
| Overdose |
11.1% |
| Weight Decreased |
11.1% |
| Weight Increased |
11.1% |
|
